Condylox (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Condylox drug offered from Actavis Pharma, Inc.. This Decreased Mitosis [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
| NON-PROPRIETARY NAME: | podofilox |
| SUBSTANCE NAME: | PODOFILOX |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Mitosis [PE] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | GEL |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1997-03-13 |
| END MARKETING DATE: | 0000-00-00 |
Condylox HUMAN PRESCRIPTION DRUG Details:
| Item Description | Condylox from Actavis Pharma, Inc. |
| LABELER NAME: | Actavis Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/g) |
| START MARKETING DATE: | 1997-03-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 52544-045_6352d35d-98cf-4674-9810-b9e485f25ef0 |
| PRODUCT NDC: | 52544-045 |
| APPLICATION NUMBER: | NDA020529 |
Other PODOFILOX Pharmaceutical Manufacturers / Labelers:
